cure
asthma
rhinosinus
copd
articl
author
review
common
natur
therapi
use
treatment
common
cold
rhinosinus
asthma
copd
viral
upper
respiratori
infect
uri
account
high
number
peopl
miss
work
school
repres
lead
acut
diagnosi
offic
set
year
unit
state
alon
common
cold
caus
sever
viral
organ
adenovirus
myxovirus
coronavirus
picornavirus
common
viral
caus
rhinoviru
usual
patient
recov
day
complic
usual
relat
extens
infect
lower
respiratori
tract
eg
bronchiti
pneumonia
nasal
ostia
eustachian
tube
eg
sinus
otiti
media
usual
care
mainli
symptomat
support
commonli
known
market
natur
supplement
describ
articl
howev
health
profession
know
herbalist
natur
health
care
provid
often
use
combin
herb
supplement
aromatherapi
forth
treat
symptom
antimicrobi
properti
discuss
formula
beyond
scope
articl
summari
present
tabl
andrographi
paniculata
annual
herb
leav
use
tradit
asian
tradit
medicin
particularli
ayurveda
treat
fever
associ
infect
approxim
speci
andrographi
known
indigen
asia
paniculata
commonli
use
andrographi
also
use
medic
condit
exampl
digest
problem
blood
cleanser
fever
sore
throat
uri
systemat
review
coon
ernst
doubleblind
control
trial
n
met
criteria
evalu
efficaci
trial
score
least
methodolog
qualiti
dose
andrographi
use
rang
mg
paniculata
alon
combin
e
senticosu
seem
promis
treatment
uncompl
uri
symptom
highest
qualiti
studi
fix
combin
standard
extract
leav
paniculata
mgd
root
e
senticosu
mgd
given
patient
uncompl
uri
within
hour
onset
symptom
outcom
measur
patient
physician
evalu
sever
symptom
base
predefin
criteria
signific
improv
note
patientmeasur
symptom
p
physicianmeasur
assess
p
improv
note
symptom
muscl
ach
cough
frequenc
presenc
product
cough
fever
sore
throat
anoth
metaanalysi
publish
year
identifi
qualifi
studi
n
report
similar
improv
symptom
sever
favor
combin
paniculata
e
senticosu
larg
n
nonrandom
studi
use
fix
combin
standard
extract
leav
paniculata
mgd
root
e
senticosu
mgd
given
day
found
signific
differ
mean
symptom
score
group
end
treatment
p
headach
nasal
throat
symptom
gener
malais
show
improv
anoth
random
control
trial
subject
receiv
mgd
paniculata
hour
onset
uri
symptom
statist
signific
improv
symptom
report
within
day
studi
compar
mgd
paniculata
paracetamol
gd
subject
random
paracetamol
highdos
paniculata
report
statist
signific
improv
symptom
day
safeti
profil
paniculata
favor
report
allerg
reaction
report
anaphylact
shock
report
anaphylact
reaction
earli
sweden
data
lack
safeti
paniculata
pregnant
breastfeed
women
avoid
addit
experiment
report
indic
paniculata
might
contracept
effect
therefor
use
avoid
men
women
attempt
conceiv
overal
evid
suggest
paniculata
alon
combin
e
senticosu
could
effect
treatment
uncompl
acut
upper
respiratori
tract
infect
ascorb
acid
watersolubl
vitamin
necessari
form
collagen
cartilag
absorpt
iron
format
blood
vessel
found
natur
fruit
eg
citru
veget
interest
use
vitamin
c
treatment
prevent
common
cold
heighten
follow
public
nobel
prize
win
scientist
linu
paul
book
vitamin
c
common
cold
follow
conduct
sever
metaanalys
demonstr
decreas
incid
number
day
ill
follow
use
vitamin
c
sinc
controversi
arisen
sever
trial
report
benefit
mainli
popul
low
vitamin
c
intak
physic
stress
other
report
benefit
initi
review
indic
despit
heterogen
studi
supplement
vitamin
c
dose
gd
consist
decreas
durat
allevi
symptom
common
cold
metaanalysi
cochran
review
group
attempt
answer
question
vitamin
c
dose
g
daili
reduc
incid
durat
sever
common
cold
use
either
continu
prophylaxi
onset
cold
symptom
data
differ
trial
involv
cold
episod
particip
initi
supplement
onset
cold
symptom
includ
data
therapeut
trial
provid
convinc
evid
reduc
durat
cold
treatment
commenc
common
cold
symptom
began
eight
trial
arm
includ
separ
respiratori
episod
cold
sever
assess
also
review
analysi
result
similarli
found
meaning
differ
vitamin
c
placebo
group
sever
cold
episod
treatment
commenc
common
cold
symptom
began
question
remain
overal
efficaci
vitamin
c
treatment
common
cold
symptom
although
firm
conclus
drawn
evid
suggest
follow
strategi
could
help
vitamin
c
effect
reduc
cold
symptom
durat
initi
treatment
within
hour
onset
symptom
vitamin
c
may
effect
subject
low
level
vitamin
c
undergo
high
physic
mental
stress
c
higher
dose
vitamin
c
g
higher
effect
lower
dose
none
vitamin
c
common
cold
trial
report
evid
vitamin
c
harm
dose
test
echinacea
speci
wide
use
market
improv
immun
system
respons
cold
flu
exact
mechan
action
immunestimul
effect
echinacea
prepar
remain
unclear
four
compound
believ
contribut
immunomodulatori
activ
echinacea
extract
alkamid
glycoprotein
polysaccharid
caffeic
acid
deriv
seem
activ
altern
complement
pathway
compon
increas
level
lymphocyt
natur
killer
cell
addit
echinacea
extract
increas
macrophag
prolifer
phagocytosi
well
secret
interferon
tumor
necrosi
factor
vitro
vivo
cochran
review
identifi
trial
n
total
echinacea
group
diagnos
common
cold
symptom
random
treat
echinacea
press
juic
stabil
alcohol
alcohol
tinctur
tablet
made
dri
extract
form
echinacea
use
outcom
measur
heterogen
treatment
group
often
use
differ
instrument
time
measur
type
analysi
descript
statist
among
trial
comparison
group
studi
among
children
receiv
press
juic
e
purpurea
herb
report
posit
result
echinacea
prepar
compar
placebo
treatment
signific
effect
report
comparison
trend
differ
overal
clinic
evid
efficaci
echinacea
treat
common
cold
symptom
remain
unclear
goldens
nativ
eastern
north
america
tradit
use
nativ
american
treatment
inflamm
respiratori
digest
urinari
tract
primari
alkaloid
found
goldens
berberin
hydrastatin
goldens
strong
astring
properti
tradit
use
help
eas
discomfort
sore
throat
herbalist
often
recommend
goldens
combin
echinacea
treatment
cold
flu
howev
current
welldesign
studi
evalu
goldens
either
alon
combin
echinacea
glodens
recommend
pregnant
breastfeed
women
zinc
essenti
miner
natur
present
food
mollusk
oyster
meat
poultri
bean
nut
whole
grain
cereal
forth
avail
adietari
supplement
data
nation
health
nutrit
examin
survey
nhane
iii
indic
adult
age
year
older
zinc
intak
less
estim
averag
requir
mgd
elderli
women
mgd
elderli
men
mild
moder
degre
zinc
defici
impair
function
activ
immun
system
particular
lymphocyt
zinc
commonli
use
varieti
condit
wound
heal
skin
ulcer
smell
tast
disord
also
market
varieti
form
treatment
viral
infect
herp
simplex
uri
initi
evid
rigor
scientif
trial
zinc
effect
cold
symptom
came
inocul
studi
neither
trial
found
direct
effect
viral
shed
either
magnitud
durat
recent
random
doubleblind
control
trial
employe
cleveland
clinic
use
zinc
glucon
mg
everi
hour
report
signific
reduct
durat
symptom
common
cold
placebocontrol
trial
mg
zinc
sulfat
daili
prophylact
mg
twice
daili
onset
cold
symptom
resolv
report
drop
mean
number
cold
vs
p
mean
number
coldrel
absenc
day
vs
day
p
shorter
durat
cold
symptom
zinc
group
versu
placebo
p
metaanalysi
identifi
trial
use
zinc
glucon
patient
cold
develop
de
novo
commun
dose
zinc
glucon
use
rang
mg
odd
ratio
presenc
cold
symptom
day
confid
interv
indic
evid
effect
zinc
lozeng
reduc
durat
common
cold
still
lack
overal
current
evid
weak
efficaci
zinc
glucon
lozeng
reduc
cold
durat
zinc
consid
rel
safe
taken
recommend
dose
studi
report
side
effect
nausea
vomit
diarrhea
highdos
zinc
also
associ
potenti
reduct
serum
copper
level
lymphocyt
stimul
highdens
lipoprotein
hdl
higher
incid
urinari
problem
among
men
benign
prostat
hyperplasia
bph
renal
lithiasi
recent
warn
regard
intranas
gelspray
post
us
food
drug
administr
possibl
loss
smell
chines
herb
formula
also
evalu
potenti
benefit
treat
common
cold
cochran
metaanalysi
identifi
studi
involv
patient
studi
rate
low
poor
qualiti
high
probabl
common
respiratori
diseas
bias
studi
includ
differ
chines
herbal
prepar
test
nearli
trial
studi
herbal
prepar
found
effect
enhanc
recoveri
control
studi
herbal
prepar
shown
equal
control
base
review
investig
conclud
unabl
recommend
kind
chines
herbal
prepar
common
cold
recent
overthecount
product
airborn
market
treatment
prevent
common
cold
gain
particular
notorieti
popular
review
product
reveal
contain
sever
ingredi
zinc
mg
echinacea
mg
vitamin
c
e
riboflavin
miner
sodium
magnesium
selenium
potassium
well
herb
ginger
chines
vitex
forsythia
forth
review
literatur
manufactur
web
site
highlight
sever
testimoni
scientif
evid
efficaci
cdc
defin
rhinosinus
previous
refer
sinus
inflamm
mucosa
sinus
paranas
structur
affect
million
individu
unit
state
year
estim
annual
cost
billion
patient
bacteri
sinus
often
report
symptom
day
facial
andor
teeth
tender
purul
nasal
discharg
virus
account
case
rhinosinus
case
resolv
spontan
rhinosinus
remain
fifth
lead
reason
antibiot
prescrib
antibiot
reserv
patient
bacteri
symptom
survey
indic
subject
chronic
rhinosinus
use
herbal
therapi
either
alon
combin
treatment
allerg
rhiniti
common
condit
current
estim
indic
million
peopl
unit
state
suffer
allerg
rhiniti
preval
chronic
condit
patient
less
year
age
peopl
affect
condit
often
report
fatigu
upper
respiratori
symptom
allerg
rhiniti
also
lead
case
chronic
rhinosinus
section
common
natur
supplement
market
treatment
rhinosinus
review
vitamin
c
report
inhibit
histamin
secret
white
blood
cell
seem
invers
relationship
ascorb
acid
level
plasma
histamin
level
initi
studi
show
oral
supplement
vitamin
c
reliabl
lower
blood
histamin
level
prospect
trial
blood
level
sever
vitamin
miner
evalu
children
n
mean
age
year
chronic
rhinosinus
compar
healthi
control
n
vitamin
c
vitamin
e
copper
zinc
level
significantli
lower
chronic
sinus
group
compar
control
vitamin
c
might
hold
promis
manag
rhinosinus
howev
evid
time
allow
definit
conclus
urtica
dioica
also
known
sting
nettl
tradit
use
treat
allerg
rhiniti
exact
mechan
action
known
howev
studi
indic
plant
nutrient
dens
histamin
serotonin
acetylcholin
present
plant
hair
author
could
identifi
clinic
studi
use
sting
nettl
sinus
howev
random
doubleblind
clinic
trial
subject
n
took
freezedri
mg
twice
daili
urtica
dioica
treatment
allerg
rhiniti
achiev
posit
result
treat
subject
report
improv
global
assess
note
symptom
abat
record
equival
increas
respons
urtica
dioica
compar
previou
medicin
safeti
sting
nettl
women
pregnant
breastfeed
establish
caution
advis
patient
diabet
bleed
disord
diuret
bromelain
proteolyt
enzym
obtain
pineappl
commonli
use
treat
rhinosinus
antiinflammatori
mucolyt
bromelain
seem
thin
nasal
secret
addit
proteolyt
activ
inflammatori
site
believ
promot
inhibit
proinflammatori
prostaglandin
biosynthesi
studi
children
acut
sinus
report
faster
symptom
recoveri
children
bromelain
compar
standard
treatment
confirm
find
earlier
doubleblind
studi
patient
acut
chronic
sinus
receiv
bromelain
complet
resolut
inflamm
nasal
mucosa
p
compar
placebo
group
initi
studi
bromelain
seem
encourag
evid
need
bromelain
oral
dosag
typic
mgd
side
effect
includ
allerg
reaction
bromelain
indigest
nausea
diarrhea
safeti
bromelain
pregnant
nurs
women
children
peopl
liver
kidney
diseas
known
quercetin
found
mani
food
onion
appl
antiinflammatori
activ
seem
result
antioxid
inhibitori
effect
inflammationproduc
enzym
quercetin
also
found
stabil
mast
cell
inhibit
releas
histamin
clinic
quercetin
seem
help
manag
allerg
rhiniti
seem
therapeut
similar
cromolyn
sodium
oral
antihistamin
small
studi
n
nasal
spray
formul
contain
extract
quercetin
given
immedi
appear
characterist
allerg
nasal
symptom
patient
experienc
rapid
signific
symptom
relief
nasal
symptom
compar
effect
antihistamin
chromogl
prepar
effect
felt
within
minut
administr
last
sever
hour
despit
posit
initi
evid
addit
studi
publish
confirm
find
common
oral
dose
mg
time
per
day
typic
use
quercetin
gener
safe
larg
dose
anecdot
report
joint
pain
gastric
discomfort
butterbur
plant
daisi
famili
asteracea
butterbur
robust
plant
thick
rhizom
larg
rhubarblik
leav
contain
activ
compound
believ
petasin
group
sesquiterpen
butterbur
use
tradit
remedi
headach
inflamm
clinic
studi
suggest
butterbur
standard
extract
ze
tablet
time
daili
may
effect
prevent
allerg
rhiniti
similar
fexofenadin
allegra
cetirizin
zyrtec
suscept
individu
howev
studi
focus
intermitt
rhiniti
conflict
suggest
better
placebo
evid
encourag
butterburr
may
prevent
allerg
rhiniti
common
respiratori
diseas
addit
studi
need
confirm
patient
liver
diseas
dysfunct
avoid
raw
butterbur
extract
potenti
hepatotox
avoid
pregnant
breastfeed
allerg
butterbur
world
health
organ
identifi
acupunctur
effect
treatment
allerg
rhiniti
includ
hay
fever
sever
small
trial
report
benefici
effect
allerg
rhiniti
allergi
exampl
random
clinic
studi
compar
activ
versu
sham
acupunctur
month
consecut
patient
allerg
rhiniti
posit
skin
test
allergen
mugwort
greater
reduct
level
specif
immunoglobulin
e
ige
p
skin
test
reaction
p
seen
group
receiv
activ
acupunctur
compar
group
receiv
sham
acupunctur
howev
recent
systemat
review
identifi
random
control
trial
rct
gener
poor
qualiti
except
highqual
studi
assess
jadad
scale
wide
varieti
outcom
measur
assess
symptom
sever
visual
analog
scale
metaanalysi
fail
show
benefit
acupunctur
treatment
symptom
sever
score
serum
ige
measur
could
account
chanc
alon
acupunctur
studi
look
treatment
sinus
show
advantag
convent
treatment
find
confirm
recent
systemat
review
highqual
rct
two
rct
compar
acupunctur
oral
pharmacolog
medic
report
posit
result
favor
acupunctur
one
studi
report
favor
effect
acupunctur
rhiniti
symptom
score
found
posit
result
nasal
symptom
score
compar
placebo
acupunctur
three
rct
fail
demonstr
benefici
effect
acupunctur
treat
prevent
symptom
allerg
rhiniti
overal
evid
effect
acupunctur
symptomat
treatment
prevent
allerg
rhiniti
remain
mix
studi
fail
show
benefici
result
season
allerg
rhiniti
although
suggest
evid
effect
manag
perenni
allerg
rhiniti
asthma
chronic
inflammatori
diseas
airway
character
revers
airflow
restrict
associ
symptom
wheez
chest
tight
short
breath
unit
state
affect
million
peopl
age
race
ethnic
group
common
chronic
diseas
childhood
clear
allopath
guidelin
treatment
accord
diseas
sever
use
cam
asthma
widespread
survey
nation
asthma
campaign
unit
kingdom
found
peopl
moder
asthma
sever
asthma
use
cam
treat
condit
minor
yet
use
cam
indic
would
consid
use
cam
asthma
futur
survey
cam
use
peopl
asthma
rhinosinus
unit
state
found
studi
popul
use
form
cam
condit
month
studi
popular
form
cam
asthma
includ
herb
breath
techniqu
includ
mindbodi
relax
techniqu
homeopathi
acupunctur
studi
patient
turn
cam
treatment
reveal
desir
person
control
treatment
percept
effect
safeti
natur
holist
well
dissatisfact
side
effect
cost
provid
interact
approach
convent
method
tabl
given
preval
cam
use
asthma
patient
use
cam
simultan
use
allopath
treatment
import
allopath
physician
awar
common
type
cam
treatment
use
abl
counsel
patient
current
evid
efficaci
risk
potenti
interact
therapi
especi
involv
herb
pharmaceut
herbal
therapi
popular
form
cam
treatment
asthma
four
class
drug
current
use
treat
asthma
b
agonist
anticholinerg
methylxanthin
cromon
origin
herbal
treatment
go
back
least
year
exampl
ephedrin
develop
tradit
chines
herbal
remedi
huang
tea
leav
herbal
origin
theophyllin
caffein
found
tea
coffe
member
famili
theophyllin
use
centuri
treatment
asthma
like
mani
cam
treatment
scientif
evid
evalu
effect
herbal
therapi
asthma
mar
poor
studi
qualiti
flaw
studi
design
three
systemat
review
herbal
therapi
asthma
conduct
last
decad
although
use
slightli
differ
methodolog
came
similar
conclus
recent
comprehens
review
investig
found
studi
assess
herbal
prepar
involv
particip
met
entri
criteria
review
small
sampl
size
dispar
outcom
measur
rel
shortterm
followup
prevent
overal
clear
conclus
efficaci
longterm
safeti
herbal
therapi
asthma
mean
durat
therapi
week
larg
variat
type
pulmonari
function
measur
symptom
score
type
subject
assess
greatli
limit
abil
review
perform
combin
outcom
data
assess
subgroup
analysi
limit
mind
result
herb
merit
comment
boswellia
branch
tree
found
india
north
africa
middl
east
close
rel
biblic
incens
frankincens
gummi
oleoresin
found
bark
use
year
ayurved
medicin
india
african
countri
treatment
varieti
diseas
includ
arthriti
asthma
mechan
action
asthma
believ
result
antiinflammatori
properti
resin
extract
inhibit
leukotrien
synthesi
releas
one
random
control
trial
adult
asthma
report
improv
forc
expiratori
volum
second
fev
forc
vital
capac
fvc
number
asthma
exacerb
wheez
subsequ
review
express
concern
signific
differ
baselin
characterist
group
rais
question
appropri
random
whether
group
compar
cochran
review
identifi
anoth
small
doubleblind
rct
patient
report
improv
fev
percentag
predict
translat
modest
chang
actual
fev
improv
peak
expiratori
flow
rate
pefr
fvc
boswellia
seem
gener
safe
although
extens
studi
safeti
toler
lack
refer
gastrointestin
side
effect
human
epigastr
pain
heartburn
nausea
diarrhea
find
hepatotox
studi
mice
caution
advis
patient
take
agent
metabol
tylophora
climb
perenni
plant
grow
india
mechan
action
seem
result
effect
tylophorin
major
alkaloid
tylophora
adren
hormon
stimul
depress
cellmedi
immun
suppress
ige
mediat
releas
cochran
systemat
review
tylophora
show
impress
shortterm
improv
clinic
outcom
attack
frequenc
symptom
sever
moder
improv
lung
function
measur
posit
effect
evid
week
investig
note
herb
may
suitabl
chronic
use
also
associ
sever
gastrointestin
side
effect
suffici
lead
investig
includ
antiemet
agent
placebo
compar
mask
treatment
group
assign
earlier
systemat
review
identifi
random
clinic
trial
demonstr
moder
improv
symptom
improv
fev
studi
show
signific
improv
compar
placebo
trial
differ
formul
dose
regimen
report
variou
studi
dose
mg
time
daili
tylophorin
per
dose
standard
safeti
data
exist
exposur
advers
effect
mainli
seem
gastrointestin
includ
nausea
vomit
seem
reduc
leav
taken
capsul
form
instead
chew
propoli
natur
flavonoidrich
resin
produc
bud
conif
poplar
tree
incorpor
bee
beeswax
combin
bee
secret
preliminari
vitro
vivo
evid
propoli
suppress
lipoxygenas
pathway
arachidon
acid
metabol
decreas
synthesi
prostaglandin
leukotrien
involv
inflamm
propoli
also
demonstr
antiiflammatori
properti
free
radicalscaveng
properti
well
antimicrobi
effect
sever
flavonoid
small
clinic
trial
report
improv
lung
paramet
fev
pefr
forc
expiratori
flow
well
reduct
nocturn
attack
compar
placebo
numer
case
report
demonstr
propoli
may
potent
allergen
sensit
agent
therefor
use
cautious
hypersensit
individu
standard
dose
recommend
prepar
found
highli
variabl
composit
recent
shortterm
iranian
studi
patient
involv
doubleblind
random
placebocontrol
trial
mgd
purpl
passion
fruit
peel
pfp
extract
novel
mixtur
bioflavonoid
asthma
symptom
show
promis
result
preval
wheez
cough
short
breath
reduc
fvc
improv
significantli
group
treat
pfp
extract
p
compar
placebo
howev
absolut
improv
rel
small
unclear
clinic
signific
signific
improv
observ
fev
investig
point
sever
possibl
intrigu
mechan
support
benefici
effect
pfp
asthma
cite
effect
flavonoid
reduc
asthmat
inflamm
known
antioxid
antiallerg
antiinflammatori
properti
well
observ
effect
lower
nitrou
oxid
product
advers
effect
report
studi
particip
make
compel
compound
studi
larger
longer
trial
sever
herb
demonstr
improv
subject
asthma
symptom
eucalyptol
ginger
pulmoflex
liuweidihuangwan
shenlingbiashusan
jaiweisijunzitang
shortterm
steroid
reduct
sever
asthmat
eucalyptol
valid
studi
result
significantli
undermin
poor
studi
design
report
qualiti
studi
herbal
therapi
part
tradit
chines
medicin
tcm
also
frequent
limit
none
trial
use
placebo
control
variabl
unspecifi
ingredi
direct
queri
cochran
review
turn
studi
investig
understand
concept
random
prevent
meaning
conclus
efficaci
boswellia
tylophora
purpl
passion
fruit
peel
extract
show
promis
asthma
treatment
studi
efficaci
side
effect
larger
better
design
need
recommend
gener
use
interest
treat
asthma
dietari
supplement
often
base
concept
relat
potenti
antiinflammatori
antioxid
effect
well
idea
modern
western
diet
defici
element
necessari
benefici
normal
lung
function
element
reput
play
potenti
role
includ
selenium
vitamin
c
e
fatti
acid
fish
oil
selenium
gain
interest
treat
asthma
base
studi
observ
asthma
patient
lower
selenium
statu
lower
activ
seleniumdepend
common
respiratori
diseas
enzym
glutathion
peroxidas
asthma
patient
along
observ
report
selenium
supplement
might
benefici
patient
intrins
asthma
import
role
cellular
elimin
hydroperoxid
cochran
systemat
review
effect
selenium
asthma
abl
locat
singl
small
doubleblind
rct
patient
receiv
standard
asthma
therapi
receiv
daili
supplement
mg
sodium
selenit
week
show
signific
increas
serum
selenium
level
platelet
glutathion
peroxidas
activ
improv
subject
asthma
symptom
fail
demonstr
improv
object
spirometri
measur
investig
specul
although
possibl
supplement
dose
given
low
dose
mg
might
benefici
base
observ
studi
conclud
insuffici
evid
assess
use
selenium
clinic
practic
subsequ
doubleblind
rct
use
mg
week
patient
document
signific
increas
selenium
serum
level
show
nonsignific
improv
qualiti
life
signific
chang
lung
function
test
lead
investig
conclud
selenium
supplement
offer
clinic
benefit
chronic
asthma
key
antioxid
vitamin
abund
extracellular
fluid
vitamin
c
supplement
interest
asthma
especi
adult
children
asthma
found
lower
concentr
vitamin
c
compar
normal
subject
prior
observ
studi
show
low
vitamin
c
intak
associ
pulmonari
dysfunct
specul
patient
asthma
may
low
suppli
vitamin
c
increas
demand
vitamin
c
face
oxid
load
result
deplet
cochran
review
vitamin
c
use
season
exerciseinduc
chronic
asthma
locat
studi
meet
review
criteria
vari
studi
protocol
rang
singl
dose
mg
daili
supplement
mg
time
rang
week
month
poor
data
report
variabl
methodolog
investig
abl
combin
data
fev
measur
studi
comment
method
random
alloc
conceal
blind
alway
clear
leav
result
open
bia
found
essenti
chang
studi
paramet
includ
lung
function
need
steroid
subject
symptom
score
conclud
studi
better
trial
design
largerscal
studi
need
small
doubleblind
rct
anoth
well
know
antioxid
vitamin
e
daili
dose
mg
week
fail
show
demonstr
benefit
lung
function
symptom
score
bronchodil
use
serum
ige
level
atop
adult
mild
moder
asthma
magnesium
recogn
use
intraven
treat
acut
asthma
exacerb
data
oral
use
treat
chronic
asthma
outpati
set
mostli
shown
benefit
small
doubleblind
rct
studi
patient
given
mg
magnesium
day
week
previou
exposur
low
magnesium
diet
show
improv
asthma
symptom
score
chang
airflow
paramet
airflow
reactiv
methacholin
bronchodil
use
anoth
welldon
doubleblind
rct
studi
asthmat
patient
receiv
supplement
magnesium
mgd
week
show
benefici
effect
outcom
measur
asthma
control
includ
airflow
reactiv
measur
symptom
score
bronchodil
use
recent
doubleblind
rct
studi
children
adolesc
use
mg
magnesium
day
month
demonstr
fewer
asthma
exacerb
less
salbutamol
use
decreas
respons
methacholin
challeng
skin
test
respons
antigen
chang
spirometri
valu
given
known
influenc
inflammatori
mediat
asthma
fish
oil
supplement
natur
topic
signific
interest
treatment
prevent
asthma
known
antiinflammatori
effect
fatti
acid
present
fish
oil
epidemiolog
studi
shown
popul
eskimo
commun
diet
high
fish
low
rate
asthma
diet
commun
becom
higher
satur
fat
asthma
incid
increas
two
small
doubleblind
rct
patient
exerciseinduc
asthma
use
fish
oil
capsul
contain
g
eicosapentaeno
acid
g
docohexaeno
acid
daili
week
demonstr
clinic
improv
pulmonari
function
respons
exercis
decreas
bronchodil
use
decreas
sputum
inflammatori
mediat
howev
cochran
systemat
review
fail
demonstr
clinic
benefit
use
marin
fatti
acid
supplement
asthma
comprehens
review
investig
identifi
studi
met
studi
inclus
criteria
found
convinc
evid
supplement
diet
marin
fatti
acid
lead
improv
asthma
symptom
asthma
medic
usag
bronchial
hyperreact
fev
evid
risk
advers
effect
identifi
conclud
interest
caveat
first
studi
concentr
mainli
supplement
marin
fatti
acid
rather
eat
fish
per
se
perhap
element
origin
food
sourc
could
benefici
effect
asthma
second
much
interest
fatti
acid
supplement
asthma
began
era
neutrophil
consid
possibl
import
role
pathogenesi
asthma
profound
antiinflammatori
effect
fatti
acid
neutrophil
function
mediat
gener
howev
eosinophil
mast
cell
believ
import
effector
cell
asthma
therefor
may
explain
rel
lack
efficaci
given
fatti
acid
lack
signific
antiinflammatori
effect
eosinophil
mast
cell
vitro
extrem
detail
comprehens
review
fatti
acid
asthma
agenc
healthcar
research
qualiti
investig
unabl
deriv
definit
conclus
benefit
pauciti
evid
welldesign
wellconduct
adequ
power
studi
cite
limit
caus
miss
data
flaw
design
noncompar
studi
paramet
found
signific
evid
harm
made
refer
ongo
prospect
studi
time
look
use
fatti
acid
asthma
prevent
children
childhood
asthma
prevent
studi
conclus
also
fail
identifi
benefici
protect
effect
anoth
recent
british
systemat
review
came
conclus
recommend
larg
random
control
studi
effect
answer
question
effect
asthma
mild
improv
asthma
symptom
score
magnesium
supplement
confirm
welldesign
doubleblind
rct
none
supplement
demonstr
benefit
use
chronic
asthma
acupunctur
acupunctur
form
therapi
deriv
tcm
involv
stimul
point
bodi
use
needl
therapeut
prevent
purpos
point
deriv
tcm
theori
relat
meridian
system
purportedli
allow
flow
qi
bodi
blockag
believ
caus
health
problem
three
comprehens
systemat
review
evalu
effect
acupunctur
asthma
approach
literatur
slightli
differ
criteria
review
techniqu
martin
colleagu
search
rct
sinc
compar
acupunctur
real
placebo
point
use
least
object
measur
pulmonari
function
took
estim
trial
met
inclus
criteria
combin
estim
standard
mean
differ
acupunctur
placebo
estim
overal
effect
cochran
systemat
review
abl
pool
data
outcom
pefr
global
assess
wellb
rct
involv
patient
met
criteria
systemat
review
passalacqua
colleagu
look
varieti
cam
modal
asthma
includ
acupunctur
without
metaanalysi
despit
differ
approach
review
arriv
similar
conclus
minor
except
review
basic
found
signific
evid
efficaci
acupunctur
asthma
whether
lung
function
paramet
subject
symptom
measur
medic
usag
herbal
medic
studi
qualiti
sampl
size
miss
inform
heterogen
measur
limit
data
pool
abil
draw
use
statist
signific
conclus
review
comment
particular
challeng
uniqu
acupunctur
research
choos
appropri
placebo
acupunctur
point
note
studi
vari
choos
nonmeridian
point
versu
nonind
legitim
acupunctur
point
placebo
control
point
use
sham
arm
studi
use
treatment
asthma
other
accord
tcm
heterogen
occur
needl
depth
durat
insert
choic
laser
versu
needl
choic
either
standard
point
versu
allow
treat
provid
individu
custom
point
depend
diagnos
made
use
tcm
nosolog
quit
foreign
western
physician
research
method
conclud
clear
recommend
larger
studi
particular
attent
natur
sham
control
point
includ
notreat
control
arm
addit
sham
group
well
need
studi
includ
patient
sever
asthma
homeopathi
found
hahnemann
begin
reli
principl
symptom
diseas
cure
substanc
provok
ultra
dilut
homeopath
remedi
select
accord
symptom
prepar
special
techniqu
involv
repeat
dilut
recent
systemat
review
identifi
studi
asthmat
patient
conduct
good
methodolog
show
margin
effect
anoth
welldon
random
doubleblind
placebocontrol
trial
month
pediatr
patient
also
fail
demonstr
benefit
term
peak
flow
rate
use
medic
symptom
score
day
school
asthma
event
global
assess
chang
homeopath
remedi
prescrib
experienc
homeopath
practition
cochran
review
identifi
trial
total
peopl
investig
note
signific
methodolog
flaw
mani
studi
preclud
pool
result
abl
find
evid
benefit
evid
variou
form
manual
therapi
chiropract
osteopath
manipul
variou
physic
therapi
techniqu
asthma
mix
recent
cochran
review
found
signific
benefit
chiropract
manipul
alexand
physic
therapi
techniqu
note
methodolog
flaw
mani
studi
limit
inform
conclus
random
singleblind
control
trial
osteopath
manipul
therapi
pediatr
asthma
patient
show
statist
signific
improv
pefr
l
per
minut
l
per
minut
howev
valid
conclus
potenti
hamper
nonblind
evalu
differ
osteopath
manipul
therapi
omt
techniqu
differ
provid
studi
address
shortfal
recommend
three
comprehens
review
studi
came
mix
conclus
role
mindbodi
relax
breath
techniqu
asthma
methodolog
flaw
studi
design
pose
challeng
deriv
valid
conclus
progress
muscl
relax
breath
retrain
yoga
appear
potenti
benefit
lung
function
selfperceiv
wellb
qualiti
life
measur
better
design
studi
recommend
deriv
valid
conclus
recent
british
rct
demonstr
improv
qualiti
life
measur
seem
effect
asthma
pathophysiolog
therefor
chang
need
antiinflammatori
medic
small
studi
use
mental
imageri
hypnosi
biofeedback
show
promis
result
approach
although
clearli
safe
also
need
research
valid
effect
mindbodi
techniqu
seem
benefit
qualiti
life
indic
asthma
homeopathi
seem
evid
benefit
poor
qualiti
studi
hamper
conclus
acupunctur
manual
therapi
copd
prevent
treatabl
diseas
frequent
associ
smoke
character
chronic
airflow
limit
fulli
revers
usual
progress
associ
abnorm
inflammatori
respons
noxiou
particl
gase
common
symptom
chronic
progress
dyspnea
sputum
product
unit
state
copd
affect
adult
popul
fourth
lead
caus
death
twelfth
lead
caus
morbid
although
cure
copd
smoke
cessat
therapeut
intervent
shown
reduc
diseas
progress
unsatisfactori
treatment
outcom
side
effect
convent
drug
steroid
theophyllin
contribut
increas
popular
cam
particular
herbal
medicin
studi
show
copd
patient
admit
use
form
cam
common
type
includ
herbal
nutrit
supplement
well
garlic
acupunctur
homeopathi
asthma
main
sourc
inform
cam
practic
often
rel
friend
common
respiratori
diseas
advertis
small
number
patient
consult
physician
cam
make
import
physician
knowledg
scientif
evid
efficaci
safeti
practic
tabl
long
histori
use
herbal
remedi
treat
copd
particularli
china
india
asian
countri
herbal
expector
base
extract
hedera
helix
ivi
thymu
vulgari
thyme
also
enjoy
consider
popular
mani
european
countri
howev
even
asthma
qualiti
evidencedbas
studi
use
herbal
treatment
copd
lack
first
comprehens
systemat
review
topic
done
investig
review
english
chines
german
literatur
final
identifi
elig
rct
placebocontrol
comparison
asthma
literatur
methodolog
qualiti
gener
low
problem
caus
small
sampl
size
lack
doubl
blind
use
placebo
control
unclear
herbal
content
nonstandard
evalu
tool
root
slowgrow
perenni
panax
plant
use
china
year
variou
ailment
major
activ
compon
ginseng
divers
group
steroid
saponin
label
ginsenosid
may
varieti
action
includ
potenti
antiinflammatori
effect
may
play
role
asthma
welldesign
doubleblind
rct
moder
sever
fev
copd
patient
israel
demonstr
mg
ginseng
extract
capsul
twice
daili
month
result
signific
improv
paramet
pulmonari
function
test
includ
maximum
voluntari
ventil
maximum
inspiratori
volum
vo
max
observ
side
effect
improv
airflow
major
peripher
airway
well
improv
exercis
capac
parallel
previou
studi
athlet
interpret
investig
indic
posit
effect
respiratori
muscl
strength
possibl
caus
postul
neurotransmitterlik
action
anoth
small
chines
studi
patient
use
daili
intraven
formul
herb
panax
ginseng
main
ingredi
day
also
show
improv
pulmonari
function
fev
vital
capac
well
walk
time
borg
symptom
score
gener
anim
studi
indic
ginseng
toxic
effect
either
acut
chronic
year
use
vitro
studi
show
panax
ginseng
may
inhibit
aggreg
platelet
reduc
platelet
adhes
reduc
internation
normal
ratio
inr
reduc
warfarin
concentr
increas
clearanc
random
doubleblind
placebocontrol
clinic
studi
done
india
patient
compar
month
plantbas
formul
herb
bryonia
alba
drosera
peltata
sundew
cepha
ipecacuanha
better
known
ipecac
combin
oral
salmeterol
theophyllin
bromhexin
placebo
patient
treat
dcbt
kr
show
statist
signific
level
improv
fev
pao
compar
equival
control
symptom
dyspnea
wheez
cough
expector
disabl
sleep
disturb
common
respiratori
diseas
better
placebo
mention
made
articl
advers
effect
studi
arm
concern
express
subsequ
letter
respons
challeng
use
nonstandard
allopath
medic
control
point
combin
oral
salmeterol
theophyllin
pose
known
cardiovascular
risk
copd
patient
express
concern
issu
heavi
metal
poison
associ
plantbas
ayurved
medicin
drosera
speci
use
hundr
year
respiratori
tract
problem
fairli
commonli
use
medicin
solitari
ingredi
part
combin
medic
roughli
regist
medic
test
individu
drosera
constitu
reveal
antiinflammatori
antispasmod
antibacteri
effect
minim
advers
effect
although
safeti
data
limit
although
purport
evid
antitumor
antiinflammatori
effect
bryonia
rate
unsaf
seriou
gastrointestin
renal
neurolog
advers
effect
report
ipecac
well
known
unit
state
previous
recommend
role
emet
case
suspect
pediatr
poison
recommend
rescind
sever
year
ago
report
myopathi
death
chronic
use
although
promis
interest
studi
done
reason
methodolog
studi
clearli
need
regard
efficaci
safeti
advers
effect
individu
herbal
ingredi
improv
least
measur
pulmonari
function
shown
salvia
miltiorrhiza
echinacea
hedera
helix
leaf
extract
studi
small
fail
use
placebo
control
methodolog
flaw
small
japanes
rct
use
mg
tradit
japanes
herbal
medicin
hochuekkito
mixtur
raw
japanes
herb
mix
set
proport
given
oral
time
day
month
show
improv
sever
marker
system
inflamm
serum
prealbumin
level
older
patient
copd
address
pulmonari
function
small
studi
variou
tcm
herbal
prepar
copd
signific
methodolog
flaw
limit
use
interpret
recommend
although
onethird
patient
copd
degre
malnutrit
often
becom
sever
advanc
endstag
diseas
unclear
whether
malnutrit
play
caus
role
clinic
deterior
whether
mere
marker
process
intrins
diseas
cochran
systemat
review
topic
investig
identifi
studi
involv
patient
meet
review
criteria
major
pertain
outpatientbas
oral
supplement
least
week
undernourish
patient
copd
use
metaanalysi
found
evid
simpl
nutrit
supplement
confer
benefit
patient
copd
term
clinic
outcom
includ
measur
effect
anthropometr
function
exercis
pulmonari
mechan
peripher
muscl
function
healthrel
qualiti
life
deriv
valid
scale
tricep
skinfold
thick
margin
higher
supplement
control
associ
meaning
health
improv
suggest
fat
deposit
patient
receiv
nutrit
supplement
chang
constitut
worthwhil
respons
therapi
howev
worth
note
week
may
short
period
supplement
investig
note
explan
poor
respons
nutrit
support
includ
increas
metabol
dietinduc
thermogenesi
tissu
hypoxia
influenc
increas
level
solubl
tumor
necrosi
factoralpha
receptor
medic
corticosteroid
research
combin
nutrit
anabol
substanc
may
prove
worthwhil
howev
recent
welldon
adequ
power
doubleblind
random
placebocontrol
trial
anabol
steroid
nandrolon
decano
creatin
combin
exercis
train
show
differ
pulmonari
function
function
exercis
capac
prospect
doubleblind
random
placebocontrol
trial
megesterol
acet
patient
show
decreas
paco
result
known
stimulatori
effect
ventil
increas
appetit
associ
weight
gain
weight
mainli
fat
benefit
respiratori
muscl
function
function
exercis
toler
singl
placebocontrol
studi
show
similar
neg
result
pomegran
juic
nacetylcystein
vitamin
e
osteopath
medic
profess
develop
varieti
techniqu
purport
improv
pulmonari
function
target
variou
aspect
musculoskelet
neuron
lymphat
compon
pulmonari
system
previou
literatur
consist
small
nonrandom
studi
fail
provid
clear
pictur
efficaci
role
omt
treatment
copd
research
kirksvil
colleg
osteopath
medicin
perform
welldesign
doubleblind
rct
singl
session
multitechniqu
omt
versu
sham
therapi
patient
year
age
look
evid
immedi
measur
chang
pulmonari
function
find
statist
signific
evid
pulmonari
function
chang
wrong
direct
omttreat
patient
worsen
residu
volum
indic
air
trap
decreas
forc
expiratori
flow
investig
conclud
studi
look
effect
individu
techniqu
studi
longerterm
pulmonari
function
respons
omt
import
understand
copd
contraind
use
therapi
sever
small
singleblind
rct
week
acupressur
acupunctur
done
patient
copd
without
placebosham
control
take
account
signific
variat
techniqu
choic
outcom
measur
methodolog
flaw
random
blind
evalu
studi
show
improv
subject
symptom
dyspnea
studi
show
improv
either
fev
walk
distanc
report
advers
effect
made
acupunctur
gener
well
toler
acupunctur
show
promis
least
improv
subject
symptom
dyspnea
copd
better
design
larger
trial
clearli
need
solid
recommend
made
acupunctur
may
play
role
improv
walk
distanc
subject
symptom
dyspnea
although
better
studi
need
otherwis
littl
evid
support
herbal
therapi
fairli
good
evid
nutrit
supplement
ineffect
osteopath
manipul
potenti
harm
extens
research
avail
selfmed
phenomenon
upper
respiratori
tract
infect
rhinosinus
asthma
copd
signific
continu
increas
current
level
common
respiratori
diseas
evid
poor
small
number
good
qualiti
studi
small
sampl
size
short
durat
variat
composit
herbal
intervent
therapi
current
review
point
sever
potenti
therapi
could
effect
either
alon
adjunct
convent
therapi
one
posit
motiv
use
cam
perceiv
safeti
howev
risk
use
herbal
remedi
includ
drug
interact
inconsist
dose
contamin
natur
toxic
risk
compound
tendenc
patient
report
neither
use
herbal
treatment
suspect
advers
reaction
herbal
therapi
physician
compar
convent
overthecount
medic
herbal
therapi
user
tend
selfmed
take
advic
friend
rel
unlik
consult
practition
use
herbal
product
blanc
colleagu
rais
concern
patient
use
altern
treatment
may
delay
appropri
use
convent
medicin
thu
increas
risk
lifethreaten
complic
